- West Pharmaceutical upgraded to Buy from Neutral at UBS
UBS upgraded West Pharmaceutical (WST) to Buy from Neutral with a price
target of $390, up from $350. The firm has incremental confidence in...
from: Yahoo Finance
|
- How Is West Pharmaceutical Services' Stock Performance Compared to Other
Medical Devices Stocks?
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs,
manufactures and sells containment and delivery systems for...
from: Nasdaq
|
- Bank of America Increases West Pharmaceutical Services (NYSE:WST) Price
Target to $355.00
Bank of America upped their price target on shares of West Pharmaceutical
Services from $350.00 to $355.00 and gave the company a "buy"...
from: MarketBeat
|
- West Pharmaceutical initiated with a Peer Perform at Wolfe Research
Wolfe Research analyst Doug Schenkel initiated coverage of West
Pharmaceutical (WST) with a Peer Perform rating and no price target West...
from: Yahoo Finance
|
- West Pharmaceutical initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated coverage of West Pharmaceutical (WST) with a Peer
Perform rating. Published first on TheFly – the ultimate source for real...
from: MSN
|
- Should You Sell Your Holdings in West Pharmaceutical Services (WST)?
ClearBridge Investments, an investment management company, released its
“ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor...
from: Yahoo Finance
|
- Wolfe Research Initiates Coverage of West Pharmaceutical Services (WST)
with Peer Perform Recommendation
Fintel reports that on December 13, 2024, Wolfe Research initiated coverage
of West Pharmaceutical Services (NYSE:WST) with a Peer Perform...
from: Nasdaq
|
- West Pharmaceutical Services, Inc. (NYSE:WST) Given Average Rating of
"Moderate Buy" by Analysts
Shares of West Pharmaceutical Services, Inc. (NYSE:WST - Get Free Report)
have earned a consensus recommendation of "Moderate Buy" from the...
from: MarketBeat
|
- West Pharmaceutical Services (NYSE:WST) Now Covered by Analysts at Wolfe
Research
Wolfe Research started coverage on West Pharmaceutical Services in a
research report on Friday. They set a "peer perform" rating for the...
from: MarketBeat
|
